Some things in academia can become so much fabric of your life that you stop counting years. The conference of the College on Problems of Drug Dependence (CPDD) is one of those things. With the 2020 conference coming up soon, this blog summarises my annotated posters presented over eight years.
A poster showed our protocol for reviewing scientific literature using the Cochrane Collaboration’s approach:
Citation: Klimas, J., Field, C. A., Cullen, W., O’Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., Dunne, C. (2012). Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Cochrane review protocol. Poster presented at CPDD conference, June 11, Palm Springs
In 2013 San Diego, CA
The first iteration of the Cochrane review of literature identified 4 trials that could not have been pooled together in a meta-analysis.
Citation: Klimas, J, Field, C A, Cullen, W, O’Gorman, C, Glynn, L, Keenan, E, . . . Dunne, C. (2013). Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Cochrane review. Poster presented at the 75th Annual Meeting of College on Problems of Drug Dependence (CPDD) and NIDA International Forum. San Diego, CA, June 15-20. (Abstract published in 2014, Drug and Alcohol Dependence, 140, e106.)
In 2014, San Juan, PR
Our poster described a new educational intervention for primary care. This University of Limerick’s pilot intervention was later used in a trial involving 16 primary care clinics. Other presentations focused on the integration of addiction treatment into primary care.
Citation: Klimas, J., Lally, K., Murphy, L., Crowley, L., Anderson, R., Meagher, D., . . . Cullen, W. (2014). Development and process evaluation of an educational intervention to support primary care of problem alcohol among drug users. Poster presented at the NIDA International Forum, June 16, San Juan, PR
In 2015 Phoenix, AZ
The 2015 poster compared alcohol screening practices in a primary care clinic to specialised opioid treatment program. It compared alcohol screening policies and practices in the United States for buprenorphine patients in a primary care setting and methadone patients seen in a specialized Opioid Treatment Program. Rates of alcohol use were elevated among methadone patients while buprenorphine patients in primary care were more likely to be screened for alcohol use disorders:
Citation: Klimas, J., Muench, J., Wiest, K., Croff, R., Rieckman, T., & McCarty, D. (2015). Alcohol screening among opioid agonist patients in a primary care and opioid treatment program. Paper presented at the NIDA International Forum, and the Conference of the College on Problems of Drugs Dependence, June 17, Phoenix, AZ.
The conference offered a good balance between the talks with quality networking time.
In 2016 Palm Springs
Using the data from the Vancouver injection drug use study, we found no impact of enrolment in opioid agonist treatment on the onset of heavy alcohol use in a community sample of people who used heroin.
Citation: Klimas, J., Wood, E., Dong, H., Nguyen, P., Milloy, M.J., Kerr, T., Hayashi, K. (2016) The impact of enrolment in methadone maintenance therapy on initiation of heavy drinking among people who use heroin. Poster presented at the 78th Annual Meeting of College on Problems of Drug Dependence (CPDD) and NIDA International Forum. Palm Springs, CA, June 15-20.
In 2017 Montreal, QC
Eligibility for heroin assisted treatment evaluated in clinical trials is typically restricted to people with treatment refractory opioid use disorder. Applying the stringent eligibility criteria from clinical trials, we identified approximately 20% of the sample potentially eligible for this treatment.
Citation: Klimas, J., Wood, E., Kerr, T., Dong, H., Montaner, J., Milloy, M-J (2017) Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and who live with HIV in a Canadian setting. Poster presented at the 79th annual conference of the College on Problems of Drug Conference (CPDD 2017) | June 20, Montreal
In 2018 San Diego, CA
Urine drug screening is often used in methadone treatment to monitor treatment progress. Our review found insufficient evidence for or against this practice. In the second poster, we revisited the arena of dual alcohol addiction and opioid use disorder treatment.
NIDA poster: McEachern, J., Adye-White, L., Moss, E., Priest, K., Gorfinkel, L., Cullen, W., Wood, E., Klimas, J. (2018) Urine drug screening frequency and health outcomes for persons on opioid agonist therapy: A policy and literature review. Poster presented at the NIDA International Forum | June 11, San Diego, CA
CPDD poster: Klimas, J., Nosova, E., Socías, E., Nolan, S., Brar, R., Hayashi, K., Milloy, M., Kerr, T., Wood, E. (2018) Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who also use alcohol in Vancouver, Canada. Poster presented at the CPDD annual meeting, June 13, San Diego, CA.
In 2019 San Antonio, TX
I had the privilege to present two posters by my trainees and two of my own. Lauren Gorfinkel and Kevin Lorenz explored the outcomes of health professionals and nurses undertaking an online addiction medicine course. I presented two posters detailing systematic reviews of literature on the risk of prescription opioid addiction and slow release oral morphine, respectively.
Gorfinkel, L., Giesler, A., Dong, H., Wood, E., Fairbairn, N., Klimas, J. (2019) Development and Evaluation of the Online Addiction Medicine Certificate: A Free Novel Program in a Canadian Setting Poster presented at the 83rd annual conference of the College on Problems of Drug Conference | June 18, San Antonio, Texas
Lorenz, K., Dong, H., Johnson, C., Robinson, S., Klimas, J. (2019) Does online substance use education improve nurses’ knowledge in addiction medicine? An Educational evaluation in a Canadian setting. Poster presented at the 83rd annual conference of the College on Problems of Drug Conference | June 19, San Antonio, Texas
Klimas, J., Simel, D., Gorfinkel, L., Fairbairn, N., Amato, L., Ahamad, K., Nolan, S., Wood, E. (2019) Strategies to identify patients at high risk of prescription opioid addiction. Poster presented at the 83rd annual conference of the College on Problems of Drug Conference | June 19, San Antonio, Texas
Klimas, J., Gorfinkel, L., Giacomuzzi, S., Ruckes, C., Socias, E.M., Fairbairn, N., Wood, E. (2019) Slow Release Oral Morphine versus Methadone for the Treatment of Opioid Use Disorder: A Systematic Review and Meta-Analysis. Poster presented at the NIDA International Forum | June 17, San Antonio, Texas
In 2020 going virtual.
The virtual conference begins on June 22nd. Details of my virtual presentations will be posted here then. Although our society changed dramatically in the last few months, I have enjoyed joining the conference for eight years. What will the world look like in the 2025? Some things will change, others stay the same.
If you enjoyed reading this post, you might also like reading my blogs from the previous eight years.